Unknown

Dataset Information

0

Carbapenemase-Producing Elizabethkingia Meningoseptica from Healthy Pigs Associated with Colistin Use in Spain.


ABSTRACT: Carbapenems are considered last-resort antimicrobials, especially for treating infections involving multidrug-resistant Gram-negative bacteria. In recent years, extended-spectrum ?-lactamase (ESBL) and carbapenemase-producing Gram-negative bacteria have become widespread in hospitals, community settings, and the environment, reducing the range of effective therapeutic alternatives. The use of colistin to treat infection caused by these multi-drug bacteria may favour the selection and persistence of carbapenem-resistant bacteria. In this study, it is described, for the first time to our knowledge, a carbapenemase-producing isolate of Elizabethkingia meningoseptica from healthy pigs in Spain. The isolate we report was recovered during a study to detect colistin-resistant bacteria from faecal samples of healthy food-production animals using a chromogenic selective medium. Unexpectedly, we found an isolate of Elizabethkingia meningoseptica with high Minimum Inhibitory Concentration (MIC) values for several antibiotics tested. Molecular analysis did not show any mcr family genes related with colistin resistance, but two carbapenemase genes, blaB-12_1 and blaGOB-17_1, were detected. This finding in healthy animals could suggest that colistin may favour the selection and persistence of carbapenem-resistant bacteria.

SUBMITTER: Miguela-Villoldo P 

PROVIDER: S-EPMC6783829 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Carbapenemase-Producing Elizabethkingia Meningoseptica from Healthy Pigs Associated with Colistin Use in Spain.

Miguela-Villoldo Pedro P   Hernández Marta M   Moreno Miguel Á MÁ   Rodríguez-Lázaro David D   Quesada Alberto A   Domínguez Lucas L   Ugarte-Ruiz María M  

Antibiotics (Basel, Switzerland) 20190911 3


Carbapenems are considered last-resort antimicrobials, especially for treating infections involving multidrug-resistant Gram-negative bacteria. In recent years, extended-spectrum β-lactamase (ESBL) and carbapenemase-producing Gram-negative bacteria have become widespread in hospitals, community settings, and the environment, reducing the range of effective therapeutic alternatives. The use of colistin to treat infection caused by these multi-drug bacteria may favour the selection and persistence  ...[more]

Similar Datasets

| S-EPMC3837857 | biostudies-literature
| S-EPMC4552966 | biostudies-literature
| S-EPMC7454067 | biostudies-literature
| S-EPMC6535532 | biostudies-literature
| PRJDB2598 | ENA
| PRJNA1166990 | ENA
| PRJDB2014 | ENA
| PRJDB2072 | ENA
| PRJDB2245 | ENA
| PRJNA1097367 | ENA